Influence of CYP2C8*3 and ABCG2 C421A genetic polymorphisms on trough concentration and molecular response of imatinib in Egyptian patients with chronic myeloid leukemia. Here, CYP2C8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.